Novee Launches Agentic Fix to Turn Validated Exploits into Implemented Fixes 
The AI Search Shift: A Survival Guide for CMOs, PR Professionals, and Website Managers 
An Architectural Approach to Solving Prompt Security Challenges 
Optical Networking At Micro Scale Tsodilo Resources Limited Announces Geotechnical Lab Results for the Preliminary Economic Assessment of Its Xaudum Iron Project in Botswana
TORONTO, ON / ACCESSWIRE / September 20, 2021 / Tsodilo Resources Limited (“Tsodilo” or the…
Evian Unveils 100% rPET Bottles Created by Loop Industries’ Innovative Recycling Technology
Committed to accelerating the development of innovative sustainable packaging solutions, evian achieves new milestone in…
Quadient Introduces iX-Series Mailing Systems and S.M.A.R.T. Essential Mail Management Software to the U.K. Market
User-focused iX-Series and S.M.A.R.T software is the most comprehensive, flexible and contemporary range of mailing…
The Media Art Festival Seasons of Media Arts is back again in the city!
17 September to 17 October, 2021 The urban Festival of Media Art Seasons of Media…
Becrypt wins Cyber/Defence Innovation Den
Government of Ontario and techUK promoting international Cyber collaboration London, UK: On 16th September, the…
Ventyx Biosciences Announces Key Appointments and Closing of $51.0 Million Series B Convertible Preferred Stock Financing Round
Drs. Sheila Gujrathi (Executive Chair), Jörn Drappa (Chief Medical Officer) and Luisa Salter-Cid (Chair of…
eureKARE announces participation of the European Innovation Council in the opening of the eureKAWARDS
eureKARE announces participation of the European Innovation Council in the opening of the eureKAWARDS Dr…
FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform
FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune…
FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform
FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune…
OSE Immunotherapeutics To Present Positive Results of Tedopi® Phase 3 Clinical Trial in Non-Small Cell Lung Cancer Patients in Secondary Resistance to Immune Checkpoint Inhibitors At the European Society for Medical Oncology (ESMO) Virtual Congress 2021
OSE Immunotherapeutics reminds the presentation on positive data of Tedopi® in non-small cell lung cancer today…
Santhera Secures CHF 45 Million in Funding and Announces Preliminary First Half-Year 2021 Financial Results
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN…
HUTCHMED Initiates a Japan Bridging Study to Support Surufatinib Registration for Advanced Neuroendocrine Tumors
Following surufatinib launch in China in January 2021; NDA acceptance by the U.S. FDA for…
Sorrento Announces an Independent Real-World Study That Reports Superior Sensitivity Results in Detecting COVID-19 Virus Infections in All-Comer General Population by COVISTIX as Compared to a Globally Leading Rapid Antigen Test
As a general screening for all-comers (i.e. COVID-19 symptomatic and asymptomatic populations), COVISTIX (n=783) has…
ESMO late-breaking data show Libtayo® (cemiplimab) and chemotherapy first-line treatment combination significantly improved overall survival in patients with advanced NSCLC
ESMO late-breaking data show Libtayo® (cemiplimab) and chemotherapy first-line treatment combination significantly improved overall survival…
Genmab and Seagen Present Interim Results From the innovaTV 205 Study for Tisotumab Vedotin Combination Therapy Treatment of Recurrent or Metastatic Cervical Cancer at ESMO Virtual Congress 2021
Media Release Tisotumab Vedotin in Combination with Carboplatin Showed Encouraging, Durable Anti-Tumor Activity as First-Line…
Novartis presents new Kisqali® data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer
With the MONALEESA-2 final analysis, only Kisqali has reported statistically significant overall survival (OS) benefit…
Junshi Biosciences Announces Expansion of Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Post-Exposure Prophylaxis for COVID-19
SHANGHAI, China, Sept. 19, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a…
Hydrogen-powered Engine Corolla Takes on the Challenge of Transporting Imported Hydrogen at Super Taikyu Series 2021 Suzuka S-tai
Toyota City, Japan, Sep 20, 2021 – (JCN Newswire) – Toyota Motor Corporation (Toyota) announced…
Dates Announced for ASEAN Ceramics as Messe Munchen & Asian Exhibition Services Collaborate to Stage the Shows from 2022
BANGKOK, Sep 20, 2021 – (ACN Newswire) – Messe Munchen, through their Southeast Asian regional…
Universal Hydrogen Announces New Engineering Development Center Located In Toulouse, France, the Heart of European Aviation
Engineering center to focus on development of lightweight liquid hydrogen capsules for Universal Hydrogen’s modular…